Boston Family Office’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $705K | Hold |
6,815
| – | – | 0.04% | 193 |
|
|
2026
Q1 | $489K | Buy |
6,815
+3,295
| +94% | +$254K | 0.03% | 223 |
|
|
2025
Q4 | $279K | Sell |
3,520
-1,800
| -34% | -$142K | 0.02% | 269 |
|
|
2025
Q3 | $401K | Hold |
5,320
| – | – | 0.03% | 226 |
|
|
2025
Q2 | $367K | Sell |
5,320
-200
| -4% | -$13.1K | 0.02% | 225 |
|
|
2025
Q1 | $374K | Sell |
5,520
-2,150
| -28% | -$129K | 0.03% | 220 |
|
|
2024
Q4 | $344K | Sell |
7,670
-1,867
| -20% | -$105K | 0.02% | 227 |
|
|
2024
Q3 | $600K | Sell |
9,537
-72,847
| -88% | -$4.25M | 0.04% | 189 |
|
|
2024
Q2 | $4.87M | Sell |
82,384
-48,921
| -37% | -$3.06M | 0.35% | 71 |
|
|
2024
Q1 | $10.5M | Sell |
131,305
-1,190
| -0.9% | -$90.9K | 0.75% | 39 |
|
|
2023
Q4 | $10.5M | Sell |
132,495
-12,910
| -9% | -$919K | 0.79% | 34 |
|
|
2023
Q3 | $10.2M | Sell |
145,405
-3,593
| -2% | -$255K | 0.83% | 37 |
|
|
2023
Q2 | $10.3M | Buy |
148,998
+74
| +0% | +$5.26K | 0.79% | 40 |
|
|
2023
Q1 | $11.1M | Sell |
148,924
-2,260
| -1% | -$190K | 0.89% | 34 |
|
|
2022
Q4 | $14.1M | Sell |
151,184
-1,232
| -0.8% | -$119K | 1.17% | 28 |
|
|
2022
Q3 | $14.5M | Sell |
152,416
-755
| -0.5% | -$74.7K | 1.29% | 27 |
|
|
2022
Q2 | $14.2M | Buy |
153,171
+918
| +0.6% | +$89.6K | 1.19% | 27 |
|
|
2022
Q1 | $15.4M | Buy |
152,253
+1,774
| +1% | +$186K | 1.1% | 32 |
|
|
2021
Q4 | $15.5M | Sell |
150,479
-163
| -0.1% | -$15.1K | 1.01% | 31 |
|
|
2021
Q3 | $12.8M | Sell |
150,642
-8,367
| -5% | -$701K | 0.93% | 35 |
|
|
2021
Q2 | $13.3M | Sell |
159,009
-824
| -0.5% | -$67.5K | 0.95% | 34 |
|
|
2021
Q1 | $12.1M | Sell |
159,833
-2,039
| -1% | -$149K | 0.91% | 37 |
|
|
2020
Q4 | $11.1M | Buy |
161,872
+6,598
| +4% | +$429K | 0.85% | 40 |
|
|
2020
Q3 | $9.07M | Buy |
155,274
+214
| +0.1% | +$13.3K | 0.82% | 43 |
|
|
2020
Q2 | $10.1M | Buy |
155,060
+3,617
| +2% | +$228K | 0.98% | 33 |
|
|
2020
Q1 | $8.98M | Buy |
151,443
+4,845
| +3% | +$323K | 1.06% | 32 |
|
|
2019
Q4 | $10.9M | Buy |
146,598
+5,615
| +4% | +$394K | 1.04% | 31 |
|
|
2019
Q3 | $8.89M | Buy |
140,983
+13,520
| +11% | +$801K | 0.92% | 38 |
|
|
2019
Q2 | $6.95M | Sell |
127,463
-4,222
| -3% | -$227K | 0.72% | 48 |
|
|
2019
Q1 | $7.1M | Buy |
131,685
+39,358
| +43% | +$2.43M | 0.77% | 45 |
|
|
2018
Q4 | $6.05M | Sell |
92,327
-23,822
| -21% | -$1.78M | 0.75% | 49 |
|
|
2018
Q3 | $9.14M | Buy |
116,149
+402
| +0.3% | +$28.7K | 0.96% | 34 |
|
|
2018
Q2 | $7.45M | Buy |
115,747
+4,607
| +4% | +$304K | 0.84% | 42 |
|
|
2018
Q1 | $6.91M | Sell |
111,140
-59
| -0.1% | -$4.23K | 0.79% | 45 |
|
|
2017
Q4 | $8.06M | Sell |
111,199
-964
| -0.9% | -$70.1K | 0.89% | 36 |
|
|
2017
Q3 | $9.12M | Buy |
112,163
+2,876
| +3% | +$227K | 1.04% | 27 |
|
|
2017
Q2 | $8.79M | Sell |
109,287
-2,388
| -2% | -$189K | 1.04% | 26 |
|
|
2017
Q1 | $8.77M | Buy |
111,675
+19,435
| +21% | +$1.55M | 1.08% | 29 |
|
|
2016
Q4 | $7.28M | Buy |
92,240
+32,514
| +54% | +$2.63M | 0.95% | 32 |
|
|
2016
Q3 | $5.32M | Sell |
59,726
-193
| -0.3% | -$18.2K | 0.69% | 48 |
|
|
2016
Q2 | $5.74M | Sell |
59,919
-1,239
| -2% | -$123K | 0.74% | 42 |
|
|
2016
Q1 | $6.34M | Buy |
61,158
+836
| +1% | +$81.3K | 0.84% | 34 |
|
|
2015
Q4 | $5.9M | Buy |
60,322
+5,529
| +10% | +$542K | 0.81% | 33 |
|
|
2015
Q3 | $5.29M | Buy |
54,793
+8,609
| +19% | +$905K | 0.74% | 41 |
|
|
2015
Q2 | $4.84M | Buy |
46,184
+119
| +0.3% | +$12.2K | 0.61% | 51 |
|
|
2015
Q1 | $4.75M | Buy |
46,065
+50
| +0.1% | +$5.06K | 0.59% | 55 |
|
|
2014
Q4 | $4.43M | Sell |
46,015
-1,106
| -2% | -$97.5K | 0.55% | 59 |
|
|
2014
Q3 | $3.75M | Buy |
47,121
+223
| +0.5% | +$17.6K | 0.48% | 69 |
|
|
2014
Q2 | $3.54M | Buy |
46,898
+1,828
| +4% | +$138K | 0.45% | 73 |
|
|
2014
Q1 | $3.37M | Buy |
45,070
+5,584
| +14% | +$394K | 0.45% | 72 |
|
|
2013
Q4 | $2.83M | Buy |
39,486
+843
| +2% | +$54.2K | 0.37% | 83 |
|
|
2013
Q3 | $2.19M | Sell |
38,643
-1,012
| -3% | -$60.3K | 0.31% | 91 |
|
|
2013
Q2 | $2.27M | Buy |
+39,655
| New | +$2.3M | 0.34% | 84 |
|
Other funds holding CVS
Boston Family Office's CVS Position: Q2 2026 in Review
Boston Family Office held its CVS Health (CVS) position steady in Q2 2026 at 6,815 shares worth $705K. The position accounts for 0.04% of the portfolio, ranked #193.
Boston Family Office first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.5M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Boston Family Office held 6,815 shares of CVS Health worth $705K as of Q2 2026.
- Boston Family Office left its CVS Health share count unchanged in Q2 2026.
- CVS Health made up 0.04% of Boston Family Office's portfolio in Q2 2026, its #193 holding.
- Boston Family Office first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- Boston Family Office's CVS Health position peaked at $15.5M in Q4 2021.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Boston Family Office's 13F filing for Q2 2026, filed 12 Aug 2026.